Pharma partnering in Asia

At Roche, finding innovative solutions for unmet medical needs is at the heart of what we do.

In order to achieve our ambitious goals, we are investing more in R&D than any other pharma company in the world. But if we want to tackle some of the biggest challenges in healthcare, we need to bring together the most brilliant minds in science - we can’t do it alone!

The innovation currently ongoing in Asia is unprecedented. We are inspired by this urge to find new scientific breakthroughs and are committed to take an active role in further accelerating this innovation as one of the global leaders in the healthcare industry.

• We have a strong history and presence in Asia and are committed to fostering breakthrough innovation in the region:

  • In China, we were the first multinational companies to open offices in the Zhangjihang Hi-Tech Park in China in 1994. Today 7,000 employees are working for Roche Pharma and Roche Diagnostics in China.

  • In Japan, Roche already entered a strategic alliance with Chugai in 2002, which is a mutually beneficial and fruitful partnership until today.

  • We have offices and a strong presence across the entire Asia Pacific region.

• 7 business development professionals are located in Shanghai and Tokyo to in-license first in class or best in disease molecules. We strive to maximize the potential of our alliances jointly with our partners and bring innovation from Asia to the world.

• Our company structure spans across diagnostics and pharma - along the whole patient journey, making us a unique partner for biotechs and academia in Asia who are looking for a global partner with strong end-to-end capabilities and a global reach.

We are looking to partner with pharma, biotech and academic institutions in Asia. We are keen to leverage our strengths as a global leader in healthcare to accelerate innovation and bring the best science from Asia to patients worldwide. We are especially looking for:

• Innovative biotechs or academic institutions from Asia working on first in class or best in disease opportunities from Discovery to Phase II Development

• For our R&D site in Shanghai, we are especially looking for partnering global opportunities in Immunology (Anti-inflammation, Inflammatory macrophages, Anti-fibrosis, Nucleic acid sensing, Immunometabolism, Synovial and endothelial cells, Podocyte protection, Renal vasodilation, Intestinal motility and Enteric neuronal activity modulation) and Oncology (Gastrointestinal (GI) cancers)

If you have an opportunity for collaboration or an interesting technology, or if you have an asset in one of our areas of interest, we would like to hear from you.